
Pfizer COVID-19 pill could cut severe illness by 89%, company says
Fox News
Pfizer Inc. announced Friday that its pill to treat novel COVID-19 was found to reduce the risk of hospitalization or death by 89% among high-risk adult patients in a clinical trial.
Similar reductions in COVID-19-related hospitalization or death were observed in patients – who were unvaccinated with mild to moderate symptoms – treated within five days of symptom onset.
Few details were reported on side effects but Pfizer said rates of problems were similar between the two groups at about 20%.
More Related News

Pizza before tomatoes? Ancient Rome's version of America's favorite food looked nothing like today's
Ancient Rome pizza at Hungary restaurant features no tomatoes or mozzarella, using garum fish sauce and olive paste. Neverland Pizzeria's dish is limited-edition.












